| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
26,500 |
23,371 |
$1.92M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,829 |
1,791 |
$376K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,251 |
4,022 |
$370K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,803 |
3,551 |
$352K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,165 |
2,100 |
$324K |
| 80053 |
Comprehensive metabolic panel |
9,482 |
8,793 |
$267K |
| J3490 |
Unclassified drugs |
5,784 |
4,842 |
$213K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,046 |
3,646 |
$198K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,914 |
1,809 |
$184K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,514 |
3,225 |
$175K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,867 |
1,798 |
$160K |
| 0270 |
|
2,866 |
2,427 |
$150K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,114 |
4,845 |
$144K |
| 71045 |
Radiologic examination, chest; single view |
6,057 |
5,796 |
$142K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,894 |
3,583 |
$132K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,867 |
9,994 |
$127K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,265 |
1,223 |
$114K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,899 |
2,748 |
$99K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
312 |
306 |
$89K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,173 |
1,061 |
$85K |
| 84484 |
|
4,212 |
3,980 |
$84K |
| 99199 |
Unlisted special service, procedure or report |
1,657 |
1,471 |
$76K |
| 83690 |
|
4,344 |
4,088 |
$69K |
| Z7502 |
|
1,737 |
1,642 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,699 |
1,649 |
$52K |
| 0301 |
|
633 |
527 |
$52K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
994 |
857 |
$51K |
| 81000 |
|
5,861 |
5,560 |
$51K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
370 |
366 |
$50K |
| 85730 |
|
4,567 |
4,361 |
$45K |
| 81025 |
|
3,643 |
3,480 |
$44K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,837 |
2,727 |
$42K |
| 87040 |
|
1,235 |
1,180 |
$38K |
| 85610 |
|
4,628 |
4,400 |
$37K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
682 |
613 |
$35K |
| 83880 |
|
1,202 |
1,168 |
$35K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
430 |
387 |
$33K |
| 87428 |
|
262 |
257 |
$29K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
289 |
279 |
$28K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,803 |
3,510 |
$25K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,236 |
1,194 |
$24K |
| 83605 |
|
1,420 |
1,360 |
$21K |
| 82150 |
|
1,543 |
1,472 |
$18K |
| 80076 |
|
800 |
785 |
$18K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
486 |
448 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,607 |
2,472 |
$16K |
| 84703 |
|
872 |
849 |
$15K |
| 0360 |
|
269 |
223 |
$15K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
349 |
321 |
$15K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,110 |
2,882 |
$15K |
| 0272 |
|
2,514 |
2,243 |
$15K |
| 0710 |
|
340 |
331 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,018 |
969 |
$14K |
| 0250 |
|
2,049 |
1,399 |
$13K |
| 81002 |
|
2,386 |
2,299 |
$12K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,289 |
1,160 |
$9K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
554 |
508 |
$8K |
| 90715 |
|
154 |
153 |
$7K |
| 87186 |
|
306 |
299 |
$7K |
| 82550 |
|
697 |
670 |
$6K |
| 73562 |
|
108 |
108 |
$6K |
| 87077 |
|
290 |
284 |
$4K |
| 85379 |
|
291 |
286 |
$4K |
| 83735 |
|
670 |
654 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
711 |
692 |
$4K |
| Z7610 |
|
314 |
290 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
86 |
81 |
$3K |
| 73610 |
|
98 |
94 |
$3K |
| 82948 |
|
559 |
489 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
200 |
185 |
$2K |
| 73630 |
|
53 |
50 |
$2K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
219 |
208 |
$2K |
| 0637 |
|
316 |
228 |
$2K |
| 73030 |
|
53 |
52 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
225 |
157 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
354 |
322 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
69 |
61 |
$1K |
| 72110 |
|
45 |
45 |
$1K |
| 73130 |
|
53 |
53 |
$1K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
59 |
59 |
$1K |
| J2060 |
Injection, lorazepam, 2 mg |
189 |
164 |
$909.78 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
58 |
58 |
$775.21 |
| 87070 |
|
53 |
53 |
$667.91 |
| 99070 |
|
179 |
149 |
$523.07 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
40 |
39 |
$430.88 |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
56 |
55 |
$383.78 |
| 84702 |
|
56 |
49 |
$383.26 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
98 |
95 |
$358.97 |
| 0300 |
|
15 |
14 |
$304.98 |
| 71010 |
|
23 |
12 |
$293.29 |
| 86901 |
|
136 |
116 |
$276.54 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
49 |
49 |
$252.31 |
| 73080 |
|
12 |
12 |
$217.06 |
| 94760 |
|
37 |
37 |
$191.87 |
| 81015 |
|
121 |
120 |
$162.55 |
| 36415 |
Collection of venous blood by venipuncture |
64 |
59 |
$130.50 |
| C9113 |
Injection, pantoprazole sodium, per vial |
76 |
70 |
$121.24 |
| 86900 |
|
81 |
66 |
$120.48 |
| J7050 |
Infusion, normal saline solution, 250 cc |
19 |
14 |
$107.12 |
| 84443 |
Thyroid stimulating hormone (TSH) |
16 |
16 |
$106.82 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
15 |
14 |
$104.50 |
| 87280 |
|
18 |
18 |
$99.59 |
| J1630 |
Injection, haloperidol, up to 5 mg |
12 |
12 |
$97.91 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
12 |
12 |
$95.48 |
| 86850 |
|
12 |
12 |
$88.56 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
14 |
13 |
$83.47 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
62 |
62 |
$82.66 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
13 |
12 |
$56.31 |
| 84439 |
|
12 |
12 |
$44.31 |
| A0425 |
Ground mileage, per statute mile |
183 |
173 |
$16.76 |
| E0601 |
Continuous positive airway pressure (cpap) device |
70 |
70 |
$0.00 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
17 |
17 |
$0.00 |
| A0424 |
Extra ambulance attendant, ground (als or bls) or air (fixed or rotary winged); (requires medical review) |
54 |
53 |
$0.00 |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
142 |
142 |
$0.00 |
| A0398 |
Als routine disposable supplies |
26 |
26 |
$0.00 |
| 0324 |
|
16 |
16 |
$0.00 |
| E0570 |
Nebulizer, with compressor |
16 |
16 |
$0.00 |